Table 4.
Quartile of C-reactive protein (mg/L) | P trend | ||||
---|---|---|---|---|---|
Lowest | Second | Third | Highest | ||
Controls | 164 | 158 | 169 | 166 | |
Size | |||||
≥5mm | |||||
Cases | 56 | 72 | 101 | 97 | |
OR (95% CI)a | 1.0 (Reference) | 1.26 (0.83–1.91) | 1.66 (1.11–2.48) | 1.64 (1.09–2.45) | 0.012 |
OR (95% CI)b | 1.0 (Reference) | 1.20 (0.78–1.84) | 1.59 (1.06–2.39) | 1.48 (0.98–2.25) | 0.031 |
OR (95% CI)c | 1.0 (Reference) | 1.15 (0.74–1.77) | 1.47 (0.97–2.23) | 1.33 (0.86–2.05) | 0.14 |
<5mm | |||||
Cases | 82 | 87 | 127 | 107 | |
OR (95% CI)a | 1.0 (Reference) | 1.10 (0.76–1.60) | 1.52 (1.06–2.17) | 1.31 (0.91–1.88) | 0.074 |
OR (95% CI)b | 1.0 (Reference) | 1.06 (0.72–1.55) | 1.50 (1.04–2.15) | 1.20 (0.83–1.76) | 0.12 |
OR (95% CI)c | 1.0 (Reference) | 0.99 (0.67–1.45) | 1.32 (0.91–1.92) | 1.02 (0.69–1.50) | 0.53 |
Number | |||||
≥2 | |||||
Cases | 43 | 75 | 98 | 98 | |
OR (95% CI)a | 1.0 (Reference) | 1.65 (1.06–2.57) | 2.02 (1.31–2.09) | 2.04 (1.33–3.14) | 0.0013 |
OR (95% CI)b | 1.0 (Reference) | 1.58 (1.00–2.48) | 1.93 (1.25–3.00) | 1.84 (1.18–2.87) | 0.0032 |
OR (95% CI)c | 1.0 (Reference) | 1.49 (0.94–2.35) | 1.71 (1.09–2.68) | 1.53 (0.96–2.43) | 0.048 |
1 | |||||
Cases | 95 | 84 | 130 | 106 | |
OR (95% CI)a | 1.0 (Reference) | 0.96 (0.66–1.38) | 1.43 (1.01–2.03) | 1.18 (0.82–1.68) | 0.16 |
OR (95% CI)b | 1.0 (Reference) | 0.91 (0.63–1.33) | 1.37 (0.96–1.96) | 1.08 (0.74–1.56) | 0.27 |
OR (95% CI)c | 1.0 (Reference) | 0.86 (0.59–1.27) | 1.26 (0.87–1.81) | 0.96 (0.65–1.40) | 0.68 |
aAdjusted for age (40–49, 50–54, 55–59, 60–64, ≥65 years), sex, and screening period.
bFurther adjusted for family colorectal cancer history, pack-years of smoking (never,≤20, 21–40, >40 pack-years), alcohol drinking (never, past, <150, 150–299, ≥300 g per week), physical activity (METs-hour/day, quartile), and history of diabetes mellitus.
cFurther adjusted for body mass index (BMI) (<21.0, 21.0–22.9, 23.0–24.9, and ≥25.0 kg/m2).